权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

NorthStar Node of the Clinical Trials Network

临床试验网络的 NorthStar 节点

基本信息

批准号：
9902692
负责人：
GAVIN BART
金额：
$ 27.7万
依托单位：
HENNEPIN HEALTHCARE RESEARCH INSTITUTE
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
起止时间：
2015-09-01 至 2020-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9902692
关键词：
Accreditation Adult Alcohols American Behavioral Caring Chronic Care Chronic Disease Clinic Clinical Clinical Sciences Clinical Trials Network Collaborations Communities Community Outreach Comorbidity County Development Diabetes Mellitus Disease Management Drug Use Disorder Electronic Health Record Federally Qualified Health Center Funding Goals Grant HIV Health Health Maintenance Organizations Health Services Health Status Health system Healthcare Healthcare Systems Home Care Services Hospitals Inpatients Institutes Integrated Health Care Systems Internal Medicine Medical Medical center Medicine Minnesota Mission Modeling National Institute of Drug Abuse Neurology Outpatients Pain management Patient Care Management Patients Pharmaceutical Preparations Physicians Population Prevalence Primary Health Care Protocols documentation Psychiatry Recording of previous events Research Research Training Residencies Risk Risk stratification Schools Science Service delivery model Services Student Health Services Students Substance Use Disorder System Time Tobacco Training Translational Research Translations United States Universities Wellness Center addiction behavioral health binge drinking burden of illness chronic pain clinical decision support economic cost health care delivery health care model health care service utilization health disparity illicit drug use innovation medical specialties opioid use disorder prescription opioid primary care setting programs readmission rates safety net smoking prevalence success support tools tobacco cessation intervention tool trauma centers treatment program university student

项目摘要

Project summary: Substance use disorders (SUD) are significant contributors to the global burden of disease. Annual direct and indirect economic costs of alcohol, tobacco, and other drugs have been estimated at $500 billion in the United States alone. An estimated 20.2 million Americans are in need of treatment for a SUD, yet fewer than 5% receive specialty treatment. The most frequent point of health care contact in the United States is outpatient primary care. Minnesota ranks 1st in the US for health status and has one of the highest rates of access to primary care in the US. The proposed NorthStar node of the NIDA Clinical Trials Network brings together diverse healthcare delivery models that excel in delivery and research of primary care. Led by internal medicine physicians with practice and research expertise in addiction, the NorthStar node includes: 1) two major non-profit integrated health systems serving more than 1 million Minnesotans through over 100 primary care clinics (HealthPartners and Allina Health); 2) a Federally Qualified Health Center (NorthPoint Health & Wellness Center); 3) an accountable care organization managing the poorest and highest healthcare utilizing populations of Minnesota's most populous county (Hennepin Health); 4) a student health center, which provides primary and behavioral care for the more than 20,000 university students (University of Minnesota's Boynton Health Services); 5) the Institute for Clinical Systems Improvement (ICSI), a non-profit health improvement organization dedicated to developing and implementing quality improvement and best-practices protocols across more than 45 health systems and 8,000 physicians; and 6) the University of Minnesota Clinical and Translational Sciences Institute. In fulfillment of the CTN mission, the NorthStar node will develop (1) models of coordinated chronic care disease management of patients with SUD, (2) risk stratification tools for opiate prescription for chronic pain management in primary care, (3) clinical decision support tools focusing on the treatment of opiate use disorders, (4) integrated models of tobacco cessation treatment and HIV primary care, and (5) effective models to reduce 30-day readmission rates for SUD patients or at-risk users discharged from inpatient general medical settings.

药物使用障碍（SUD）是全球疾病负担的重要贡献者。酒精、烟草和其他药物每年的直接和间接经济成本估计为500美元。仅在美国就有10亿美元。估计有2020万美国人需要治疗SUD，只有不到5%的人接受专科治疗。美国最频繁的医疗保健接触点是门诊初级保健。明尼苏达州的健康状况在美国排名第一，并且是最高的健康状况之一。在美国获得初级保健。NIDA临床试验网络的NorthStar节点在初级保健的提供和研究方面表现出色的各种医疗保健提供模式。由内部领导在成瘾方面具有实践和研究专长的医学医生，NorthStar节点包括：1）两个主要的非营利性综合卫生系统，通过100多个初级卫生保健中心，为100多万明尼苏达州人提供服务。护理诊所（HealthPartners和Allina Health）; 2）联邦合格的健康中心（NorthPoint Health & 健康中心）; 3）一个负责任的护理组织，管理最贫穷和最高的医疗保健利用明尼苏达州人口最多的县（亨内平健康）的人口; 4）学生健康中心，为超过20，000名大学生提供初级和行为护理（明尼苏达大学的博因顿卫生服务）; 5）临床系统改进研究所（ICSI），一个非营利性的健康致力于开发和实施质量改进和最佳实践的改进组织超过45个卫生系统和8,000名医生的协议;以及6）明尼苏达大学临床和转化科学研究所。为了完成CTN的使命，北极星节点将开发 (1)SUD患者的协调慢性护理疾病管理模型，（2）风险分层工具用于初级保健中慢性疼痛管理的阿片类药物处方，（3）临床决策支持工具，（4）戒烟治疗和艾滋病毒初级治疗的综合模式护理，和（5）有效的模式，以减少30天再入院率的SUD患者或有风险的用户出院从住院的普通医疗机构。